How AI supports biotech launch strategy, distributor selection, pricing corridors, and demand modeling in emerging and small markets.
AI pricing strategy in APAC and Middle East biotech markets: beyond the EU5 reference price Most biotech companies price their products in APAC and the Middle East by anchoring to the EU5 reference price and adjusting downward. This approach has structural problems that compound across products and markets over a commercial lifecycle. It ignores local […]
AI Launch Strategy in Emerging Markets: Why the Playbook That Works in the EU5 Fails Everywhere Else The EU5 launch model assumes things that do not exist in emerging markets. Structured reimbursement timelines. Published HTA criteria. Standardised payer processes that experienced market access teams can navigate from precedent. Emerging markets in Central and Eastern Europe,
AI Launch Strategy in Emerging Markets: Beyond the EU5 Playbook Read More »
